Menopause Supplements: What the Evidence Shows

Educational only. Not medical advice. Supplements are not regulated by the FDA for safety and efficacy in the same way as prescription drugs. Quality, potency, and purity vary between manufacturers. Some supplements interact with medications. Discuss any supplement use with your clinician.

The menopause supplement industry is a multi-billion dollar market built on the gap between what women need (relief) and what their healthcare system provides (too often, dismissal). When a clinician says “this is just menopause” and sends you home without treatment, the supplement aisle at Whole Foods is waiting with promises of “natural” relief.

Some of these products have modest evidence behind them. Most do not. None approach the efficacy of HRT for vasomotor symptoms. And the “natural” label obscures an important truth: natural does not mean effective, natural does not mean safe, and natural does not mean regulated.

This guide grades the evidence honestly so you can make informed decisions rather than expensive ones.

For each supplement: what it is, what the evidence shows, and whether it is worth trying.

What it is. Herbal extract from the root of the black cohosh plant. The most studied herbal supplement for menopausal symptoms.

What the evidence shows. Mixed. Some trials show modest improvement in hot flash frequency and severity. Others show no benefit over placebo. A 2012 Cochrane review concluded that the evidence was insufficient to support its use. Individual trials vary in quality, dose, and formulation, making it difficult to draw firm conclusions. If it works, the effect size is small compared to HRT or even non-hormonal prescription options.

Safety. Generally well-tolerated. Rare reports of liver toxicity have led to warnings in some countries, though causality is debated. Should be avoided in women with liver disease. Not recommended for women with hormone-sensitive cancers (mechanism of action is not fully understood - whether it has estrogenic activity is debated).

Verdict. Modest potential benefit, minimal risk for most women. Reasonable to try for mild symptoms if you prefer non-prescription options. Do not expect HRT-level relief. Choose a standardized extract from a reputable manufacturer. If no improvement after 8 to 12 weeks, it is not working.

What it is. Plant compounds that weakly bind estrogen receptors. Found in soy foods (tofu, edamame, soy milk) and available as supplements.

What the evidence shows. Modest at best. A meta-analysis found a small reduction in hot flash frequency (approximately 20-25% beyond placebo). The effect is inconsistent and varies by individual - some women metabolize isoflavones into equol (a more potent estrogen receptor agonist) and may respond better. Approximately 30 to 50% of Western women produce equol. Dietary soy (whole foods) may be more effective than isolated supplement form.

Safety. Generally safe from food sources. Supplement doses are higher and more concentrated. The effect on hormone-sensitive cancers is debated - moderate dietary soy appears safe and may even be protective, but high-dose supplements in women with breast cancer are not recommended without oncology guidance.

Verdict. Eating more soy foods is reasonable and has broader health benefits. Soy isoflavone supplements for hot flashes have weak evidence and should not be expected to meaningfully replace HRT. If you are Asian and grew up eating soy (higher equol production), dietary soy may be more helpful for you than for women without lifelong soy consumption.

What it is. Oil from the seeds of the evening primrose plant, containing gamma-linolenic acid (GLA).

What the evidence shows. No convincing evidence for hot flash reduction. Controlled trials have consistently failed to show benefit over placebo for vasomotor symptoms. It appears in nearly every “menopause supplement” stack despite the evidence not supporting its use for this indication.

Safety. Generally safe. Can cause GI symptoms. Interacts with anticoagulants.

Verdict. Not recommended for vasomotor symptoms. The evidence does not support the claim.

What it is. Essential mineral involved in hundreds of enzymatic processes.

What the evidence shows. No good evidence for hot flash reduction specifically. Some evidence for improved sleep quality (magnesium glycinate or threonate taken at bedtime). May help with muscle cramps and restless legs. Mild anxiolytic effect in some individuals. Many women are mildly magnesium-deficient, making supplementation reasonable on general health grounds regardless of menopausal symptoms.

Safety. Generally safe at recommended doses (200 to 400 mg daily). Loose stools at higher doses (particularly magnesium citrate or oxide). Use glycinate or threonate for sleep benefit with less GI effect.

Verdict. Worth taking for general health and sleep support. Not a menopause treatment per se, but addresses a common deficiency and may improve sleep and mood at the margins.

What it is. Non-psychoactive compound from the cannabis plant.

What the evidence shows. No rigorous evidence for menopausal symptoms specifically. Anecdotal reports of improved sleep and reduced anxiety are common, but controlled trials for menopause are lacking. CBD for insomnia has mixed evidence even outside the menopause context. The current enthusiasm significantly exceeds the evidence base.

Safety. Variable. Unregulated market means potency and purity are inconsistent. Can interact with medications metabolized by CYP enzymes (many common drugs). Drowsiness, GI symptoms, appetite changes.

Verdict. If you find it helps your sleep or anxiety, the risk is generally low. But “I tried CBD for my menopause” is not evidence-based medicine, and it should not delay pursuit of treatments with actual data behind them.

What it is. Contains isoflavones similar to soy.

What the evidence shows. Similar to soy isoflavones - weak, inconsistent evidence for modest hot flash reduction.

Verdict. Same as soy isoflavones. Modest potential, minimal risk, do not expect significant relief.

What they are. Herbs marketed for stress resilience and hormonal balance.

What the evidence shows. Ashwagandha has some evidence for stress reduction and mild anxiolytic effect, but not specifically for menopausal symptoms. Maca has a few small trials suggesting modest improvement in sexual function and mood during menopause, but the evidence is too preliminary for strong conclusions. Rhodiola has stress-reduction data but nothing specific to menopause.

Verdict. These are stress-management supplements with preliminary general evidence. They are not menopause treatments. If you find them helpful for stress and general wellbeing, the risk is low. They are not substitutes for evidence-based menopause management.

If your symptoms are mild and you want to try a non-prescription approach first, black cohosh (standardized extract, 8-12 week trial), dietary soy, and magnesium at bedtime represent the most reasonable options. Set a time limit - if you do not see meaningful improvement in 8-12 weeks, move to evidence-based treatments.

If your symptoms are moderate to severe, supplements are not going to provide adequate relief. The efficacy gap between supplements and prescription treatments (HRT or non-hormonal medications) is substantial. Using supplements to avoid “chemicals” while suffering through preventable symptoms is not a health-protective choice - it is a marketing-influenced one.